Related Experiment Video
Updated: May 28, 2025

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Quantitative Assessment of CT Pulmonary Angiogram (CTPA) in SCD Patients in Comparison to non-SCD Cases in Saudi
Dunya Alfaraj1, Hussain Alkhawaja2, Mohannad Alghamdi1
1Department of Emergency, King Fahad Hospital of the University, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
Insights
Sickle cell disease (SCD) patients showed no difference in pulmonary embolism diagnosis rates via CT pulmonary angiography (CTPA). However, lower main pulmonary artery enhancement in SCD patients suggests reduced CTPA sensitivity for PE detection.
Area of Science:
- Radiology
- Cardiovascular Imaging
- Pulmonary Medicine
Background:
- Sickle cell disease (SCD) is a genetic blood disorder with widespread systemic complications.
- SCD is most prevalent in specific global regions, including sub-Saharan Africa, the Mediterranean, and the Middle East.
- Saudi Arabia exhibits considerable variation in SCD prevalence and disease severity across its provinces.
Purpose of the Study:
- To compare CT pulmonary angiography (CTPA) quality and pulmonary embolism (PE) detection rates between SCD and non-SCD patients.
- To investigate potential discrepancies in CTPA sensitivity and clinical outcomes for PE diagnosis in SCD patients.
- To evaluate the impact of SCD on the diagnostic accuracy of CTPA for PE.
Main Methods:
- A retrospective study compared 60 adult SCD patients with 60 age-matched non-SCD controls.
- All participants were evaluated for suspected PE using multi-detector CT (MDCT) scanner in the emergency department.
- Data on demographics, clinical information, and CT findings were extracted from electronic health records.
Main Results:
- The rate of positive CTPA for PE was similar between SCD (13.3%) and non-SCD (18.3%) patients (p=0.453).
- SCD patients had significantly lower contrast enhancement in the main pulmonary artery (249.9 HU vs. 283.7 HU; p=0.043).
- Hemoglobin levels were significantly lower in SCD patients (p<0.001).
Conclusions:
- CTPA demonstrated no significant difference in positive PE detection rates between SCD and non-SCD patients.
- Reduced main pulmonary artery enhancement in SCD patients suggests potentially lower CT angiography sensitivity for PE detection.
- Protocol optimization for individualized CTPA protocols is recommended to improve enhancement quality and diagnostic certainty in SCD patients.
Background:
Sickle cell disease (SCD) is a genetic disorder caused by a mutation in the β-globin gene, leading to systemic complications, including stroke, avascular necrosis, and acute chest syndrome. The disease is most prevalent in regions such as sub-Saharan Africa, the Mediterranean, and the Middle East, with Saudi Arabia showing significant variability in prevalence and severity across its provinces.
Objectives:
This study focuses on comparing the quality of CT pulmonary angiography (CTPA) and the rates of pulmonary embolism (PE) diagnosis between SCD and non-SCD patients, addressing discrepancies in detection sensitivity and clinical outcomes.
Methods:
We conducted a retrospective comparison between 60 adult SCD patients and 60 age-matched controls, all of whom were evaluated for suspected PE in our emergency department using an MDCT scanner. Data, including demographic and clinical information, as well as CT findings, were extracted from electronic health records.
Results:
In SCD patients, the rate of positive CT pulmonary angiograms was 13.3% (8/60), while in non-SCD matched controls, it was 18.3% (11/60). There was no significant difference in the rate of positive CTPA studies (p=0.453). SCD patients exhibited significantly lower enhancement in the main pulmonary artery (PA) (mean 249.9 HU) compared to control subjects (mean 283.7 HU) (p-value= 0.043). Moreover, hemoglobin levels were notably lower in SCD patients (p-value < 0.001).
Conclusion:
SCD patients demonstrated no significant difference in the rate of positive studies for acute PE when compared with controls undergoing CTPA. Furthermore, the lower main PA enhancement in SCD patients supports the hypothesis suggesting reduced sensitivity of CT angiography in detecting PE in this population. Quality improvement initiatives should concentrate on individualized protocol optimization to enhance enhancement quality and increase the likelihood of a definitive diagnosis.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...